BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 32461620)

  • 1. Pan-sarcoma genomic analysis of KMT2A rearrangements reveals distinct subtypes defined by YAP1-KMT2A-YAP1 and VIM-KMT2A fusions.
    Massoth LR; Hung YP; Nardi V; Nielsen GP; Hasserjian RP; Louissaint A; Fisch AS; Deshpande V; Zukerberg LR; Lennerz JK; Selig M; Glomski K; Patel PJ; Williams KJ; Sokol ES; Alexander BM; Vergilio JA; Ross JS; Pavlick DC; Chebib I; Williams EA
    Mod Pathol; 2020 Nov; 33(11):2307-2317. PubMed ID: 32461620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KMT2A (MLL) fusions in aggressive sarcomas in young adults.
    Yoshida A; Arai Y; Tanzawa Y; Wakai S; Hama N; Kawai A; Shibata T
    Histopathology; 2019 Oct; 75(4):508-516. PubMed ID: 31136005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent YAP1 and KMT2A Gene Rearrangements in a Subset of MUC4-negative Sclerosing Epithelioid Fibrosarcoma.
    Kao YC; Lee JC; Zhang L; Sung YS; Swanson D; Hsieh TH; Liu YR; Agaram NP; Huang HY; Dickson BC; Antonescu CR
    Am J Surg Pathol; 2020 Mar; 44(3):368-377. PubMed ID: 31592798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VIM::KMT2A-rearranged sarcomas: A report of two new cases confirming an entity with distinct histologic features.
    Almohsen SS; Griffin AM; Dickson BC; Demicco EG
    Genes Chromosomes Cancer; 2023 Jul; 62(7):405-411. PubMed ID: 36959690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent Fusions Between YAP1 and KMT2A in Morphologically Distinct Neoplasms Within the Spectrum of Low-grade Fibromyxoid Sarcoma and Sclerosing Epithelioid Fibrosarcoma.
    Puls F; Agaimy A; Flucke U; Mentzel T; Sumathi VP; Ploegmakers M; Stoehr R; Kindblom LG; Hansson M; Sydow S; Arbajian E; Mertens F
    Am J Surg Pathol; 2020 May; 44(5):594-606. PubMed ID: 31913156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KMT2A-rearranged sarcoma with unusual fusion gene CBX6::KMT2A::PYGO1.
    Nakamura H; Kukita Y; Wakamatsu T; Takenaka S; Yoshida K; Yagi T
    Virchows Arch; 2023 Dec; 483(6):891-897. PubMed ID: 37713130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insertion of the CXXC domain of KMT2A into YAP1: An unusual mechanism behind the formation of a chimeric oncogenic protein.
    Teku G; Nilsson J; Magnusson L; Sydow S; Flucke U; Puls F; Mitra S; Mertens F
    Genes Chromosomes Cancer; 2023 Nov; 62(11):633-640. PubMed ID: 37246732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sclerosing Epithelioid Fibrosarcoma: A Distinct Sarcoma With Aggressive Features.
    Warmke LM; Meis JM
    Am J Surg Pathol; 2021 Mar; 45(3):317-328. PubMed ID: 32769431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement.
    Doyle LA; Wang WL; Dal Cin P; Lopez-Terrada D; Mertens F; Lazar AJ; Fletcher CD; Hornick JL
    Am J Surg Pathol; 2012 Oct; 36(10):1444-51. PubMed ID: 22982887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
    Hasegawa N; Hayashi T; Niizuma H; Kikuta K; Imanishi J; Endo M; Ikeuchi H; Sasa K; Sano K; Hirabayashi K; Takagi T; Ishijima M; Kato S; Kohsaka S; Saito T; Suehara Y
    Clin Orthop Relat Res; 2024 Mar; 482(3):549-563. PubMed ID: 38014853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent BRAF Gene Fusions in a Subset of Pediatric Spindle Cell Sarcomas: Expanding the Genetic Spectrum of Tumors With Overlapping Features With Infantile Fibrosarcoma.
    Kao YC; Fletcher CDM; Alaggio R; Wexler L; Zhang L; Sung YS; Orhan D; Chang WC; Swanson D; Dickson BC; Antonescu CR
    Am J Surg Pathol; 2018 Jan; 42(1):28-38. PubMed ID: 28877062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent BCOR Internal Tandem Duplication and YWHAE-NUTM2B Fusions in Soft Tissue Undifferentiated Round Cell Sarcoma of Infancy: Overlapping Genetic Features With Clear Cell Sarcoma of Kidney.
    Kao YC; Sung YS; Zhang L; Huang SC; Argani P; Chung CT; Graf NS; Wright DC; Kellie SJ; Agaram NP; Ludwig K; Zin A; Alaggio R; Antonescu CR
    Am J Surg Pathol; 2016 Aug; 40(8):1009-20. PubMed ID: 26945340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCOR-CCNB3 fusions are frequent in undifferentiated sarcomas of male children.
    Peters TL; Kumar V; Polikepahad S; Lin FY; Sarabia SF; Liang Y; Wang WL; Lazar AJ; Doddapaneni H; Chao H; Muzny DM; Wheeler DA; Okcu MF; Plon SE; Hicks MJ; López-Terrada D; Parsons DW; Roy A
    Mod Pathol; 2015 Apr; 28(4):575-86. PubMed ID: 25360585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcomas With RAD51B Fusions Are Associated With a Heterogeneous Phenotype.
    Chang HY; Dermawan J; Sharma A; Dickson B; Turashvili G; Torrence D; Nucci M; Chiang S; Oliva E; Kirchner M; Stenzinger A; Mechtersheimer G; Antonescu C
    Mod Pathol; 2024 Feb; 37(2):100402. PubMed ID: 38141829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NUTM1-rearranged colorectal sarcoma: a clinicopathologically and genetically distinctive malignant neoplasm with a poor prognosis.
    Van Treeck BJ; Thangaiah JJ; Torres-Mora J; Stevens TM; Rothermundt C; Fassan M; Loupakis F; Diebold J; Hornick JL; Halling KC; Folpe AL
    Mod Pathol; 2021 Aug; 34(8):1547-1557. PubMed ID: 33714983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small Round Blue Cell Sarcoma Other Than Ewing Sarcoma: What Should an Oncologist Know?
    Davis JL; Rudzinski ER
    Curr Treat Options Oncol; 2020 Sep; 21(11):90. PubMed ID: 32875423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudoendocrine Sarcoma: Clinicopathologic Analysis of 23 Cases of a Distinctive Soft Tissue Neoplasm With Metastatic Potential, Recurrent CTNNB1 Mutations, and a Predilection for Truncal Locations.
    Papke DJ; Dickson BC; Sholl L; Fletcher CDM
    Am J Surg Pathol; 2022 Jan; 46(1):33-43. PubMed ID: 34081037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New fusion sarcomas: histopathology and clinical significance of selected entities.
    Miettinen M; Felisiak-Golabek A; Luiña Contreras A; Glod J; Kaplan RN; Killian JK; Lasota J
    Hum Pathol; 2019 Apr; 86():57-65. PubMed ID: 30633925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spindle Cell Tumors With RET Gene Fusions Exhibit a Morphologic Spectrum Akin to Tumors With NTRK Gene Fusions.
    Antonescu CR; Dickson BC; Swanson D; Zhang L; Sung YS; Kao YC; Chang WC; Ran L; Pappo A; Bahrami A; Chi P; Fletcher CD
    Am J Surg Pathol; 2019 Oct; 43(10):1384-1391. PubMed ID: 31219820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of Fibrosarcoma.
    Chiang S; Cotzia P; Hyman DM; Drilon A; Tap WD; Zhang L; Hechtman JF; Frosina D; Jungbluth AA; Murali R; Park KJ; Soslow RA; Oliva E; Iafrate AJ; Benayed R; Ladanyi M; Antonescu CR
    Am J Surg Pathol; 2018 Jun; 42(6):791-798. PubMed ID: 29553955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.